1. Home
  2. SHIM vs RCEL Comparison

SHIM vs RCEL Comparison

Compare SHIM & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.70

Market Cap

149.2M

Sector

N/A

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$5.02

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
RCEL
Founded
1990
N/A
Country
United States
United States
Employees
N/A
226
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.2M
126.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SHIM
RCEL
Price
$3.70
$5.02
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
133.6K
358.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
81.95
N/A
EPS
N/A
N/A
Revenue
$492,844,000.00
N/A
Revenue This Year
$13.99
$17.17
Revenue Next Year
$6.94
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
2.63
N/A
52 Week Low
$1.58
$3.22
52 Week High
$6.76
$7.12

Technical Indicators

Market Signals
Indicator
SHIM
RCEL
Relative Strength Index (RSI) 45.83 61.48
Support Level $3.43 $3.47
Resistance Level $4.10 $5.32
Average True Range (ATR) 0.34 0.45
MACD -0.01 0.05
Stochastic Oscillator 17.20 61.53

Price Performance

Historical Comparison
SHIM
RCEL

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: